O. Graciela Scharovsky
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Pablo MatarViviana R. RozadosV. R. RozadosMaría J. RicoSilvia GervasoniMariano F. Zacarías FluckGabriel A. RabinovichDiego O. Croci
- Topics
- Immunotherapy and Immune Responses (11 papers)Cancer Cells and Metastasis (9 papers)Immune Cell Function and Interaction (9 papers)
- Cited by
- OncologyImmunologyCancer Research
- Journals
- SHILAP Revista de lepidopterologíaCancer ResearchScientific Reports
- Partner nations
- ArgentinaUnited StatesSpain
In The Last Decade
O. Graciela Scharovsky
47 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 101
- Oncology 479
- Molecular Biology 370
- Immunology 321
- Cancer Research 221
- Pulmonary and Respiratory Medicine 130
Countries citing papers authored by O. Graciela Scharovsky
This map shows the geographic impact of O. Graciela Scharovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Graciela Scharovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Graciela Scharovsky more than expected).
Fields of papers citing papers by O. Graciela Scharovsky
This network shows the impact of papers produced by O. Graciela Scharovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Graciela Scharovsky. The network helps show where O. Graciela Scharovsky may publish in the future.
Co-authorship network of co-authors of O. Graciela Scharovsky
This figure shows the co-authorship network connecting the top 25 collaborators of O. Graciela Scharovsky. A scholar is included among the top collaborators of O. Graciela Scharovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Graciela Scharovsky. O. Graciela Scharovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 21 | |
| 3 | 10 | |
| 4 | 4 | |
| 5 | 23 | |
| 6 | 26 | |
| 7 | 3 | |
| 8 | 15 | |
| 9 | 138 | |
| 10 | 27 | |
| 11 | 22 | |
| 12 | 182 | |
| 13 | 6 | |
| 14 | Metronomic therapy with Cyclophosphamide or Doxorubicin inhibits mouse mammary adenocarcinoma growth and metastasis development | 4 |
| 15 | 43 | |
| 16 | 41 | |
| 17 | 43 | |
| 18 | 39 | |
| 19 | 34 | |
| 20 | 12 |
About O. Graciela Scharovsky
O. Graciela Scharovsky is a scholar working on Oncology, Cancer Research and Immunology, having authored 52 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Cancer Cells and Metastasis (9 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Oncology (479 citations), Immunology (321 citations) and Cancer Research (221 citations). O. Graciela Scharovsky has collaborated with scholars based in Argentina, United States and Spain. Frequent co-authors include Pablo Matar, Viviana R. Rozados, V. R. Rozados, María J. Rico, Silvia Gervasoni, Mariano F. Zacarías Fluck, Gabriel A. Rabinovich, Diego O. Croci, R. Daniel Bonfil and Eduardo Roggero. Their work appears in journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.